Total Hip Arthroplasty in Patients with Diabetes Mellitus

Kuen Tak Suh; Hong Seok Lee; Myoung Soo Kim; Jung Sub Lee; Jeung-Il Kim

doi:10.4055/jkoa.2009.44.5.526

Journal List > J Korean Orthop Assoc > v.44(5) > 1012941

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Suh, Lee, Kim, Lee, and Kim: Total Hip Arthroplasty in Patients with Diabetes Mellitus

Original Article

Journal of the Korean Orthopaedic Association

Journal of the Korean Orthopaedic Association 2009; 44(5): 526-532.

Published online: 23 September 2009

DOI: https://doi.org/10.4055/jkoa.2009.44.5.526

Total Hip Arthroplasty in Patients with Diabetes Mellitus

Kuen Tak Suh, M.D., Hong Seok Lee, M.D., Myoung Soo Kim, M.D., Jung Sub Lee, M.D., Jeung-Il Kim, M.D.

Department of Orthopedic Surgery, Pusan National University School of Medicine, Busan, Korea.

Correspondence to Kuen Tak Suh, M.D. Department of Orthopaedic Surgery, Pusan National University Yangsan Hospital, Beomeo-ri, Mulgeum-eup, Yangsan 626-770, Korea. Tel: +82.51-510-8000, Fax: +82.51-510-8026, kuentak@pusan.ac.kr

Received 19 February 2009 Accepted 22 June 2009

Abstract

Purpose

The purpose of present study is to analyze the incidence and the predisposing factors for postoperative complications that diabetes mellitus (DM) patients suffer after undergoing total hip arthroplasty.

Materials and Methods

Among the 379 patients who underwent primary cementless total hip arthroplasty from September 1998 to February 2007, fifty-nine patients (62 hips) who had DM were selected and the other 320 patients (378 hips) without DM were set as a control group to perform comparative analysis. The mean follow up period was 36 months (range, 12-117 months) and the mean age of patients was 55.5 years (range, 16-79 years). The preoperative and annual postoperative Harris Hip Score (HHS) and the postoperative complications were checked. We analyzed the factors that were associated with the incidence of postoperative complications in DM patients.

Results

The DM group had a higher incidence of urinary tract infection and a longer admission period than did non-DM group (p=0.001 and p=0.002). The HHS was 52 and 53 (p=0.185), respectively, for the DM patients and the non-DM patients preoperatively, and it was 93 and 95 (p=0.467), respectively, at the last follow up. The predisposing factors for postoperative complications in DM patients are a high hemoglobin A1c (HbA1c) level and comorbidities.

Conclusion

Total hip arthroplasty in DM patients is associated with a higher incidence of postoperative complications and a prolonged admission period. A high HbA1c level and comorbidities are considered to have significant associations with these complications.

Keywords: Diabetes mellitus, Total hip arthroplasty, Complications

Figures and Tables

Table 1

Comparison of the Patients with and without Diabetes Mellitus

^*DM, patients with diabetes mellitus.

Table 2

The Characteristics of the Patients with Diabetes Mellitus

Table 3

Average Clinical Score

^*DM, patients with diabetes mellitus.

Table 4

Complications Comparing Individuals with and without Diabetes Mellitus

^*DM, patients with diabetes mellitus.

Table 5

Statistical Analysis of the Relationships between Preoperative Factors and Postoperative Complications in Diabetes Mellitus Group

References

1. Centers for Disease Control: National Diabetes Fact Sheet. Division of Diabetes Translation: National Center for Chronic Disease Prevention and Health Promotion. 2002. Atlanta: Centers for Disease Control and Prevention.

2. The committee on the epidemiology of diabetes mellitus. Korean Diabetes Association. The epidemiology of diabetes mellitus in Korea. 2005.

3. Fitzgerald RH Jr, Nolan DR, Ilstrup DM, Van Scoy RE, Washington JA 2nd, Coventry MB. Deep wound sepsis following total hip arthroplasty. . J Bone Joint Surg Am. 1977. 59:847–855.

4. Glynn MK, Sheehan JM. The significance of asymptomatic bacteriuria in patients undergoing hip/knee arthroplasty. Clin Orthop Relat Res. 1984. 185:151–154.

5. Goodson WH 3rd, Hung TK. Studies of wound healing in experimental diabetes mellitus. J Surg Res. 1977. 22:221–227.

6. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999. 341:1906–1912.

7. Bolognesi MP, Marchant MH Jr, Viens NA, Cook C, Pietrobon R, Vail TP. The impact of diabetes on perioperative patient outcomes after total hip and total knee arthroplasty in the United States. J Arthroplasty. 2008. 23:Suppl. 92–98.

8. Moeckel B, Huo MH, Salvati EA, Pellicci PM. Total hip arthroplasty in patients with diabetes mellitus. J Arthroplasty. 1993. 8:279–284.

9. Vannini P, Ciavarella A, Olmi R, et al. Diabetes as pro-infective risk factor in total hip replacement. Acta Diabetol Lat. 1984. 21:275–280.

10. Kurzweil PR. Antibiotic prophylaxis for arthroscopic surgery. Arthroscopy. 2006. 22:452–454.

11. Jahoda D, Nyc O, Pokorný D, Landor I, Sosna A. Antibiotic treatment for prevention of infectious complications in joint replacement. Acta Chir Orthop Traumatol Cech. 2006. 73:108–114.

12. Loder RT. The influence of diabetes mellitus on the healing of closed fractures. Clin Orthop Relat Res. 1988. 232:210–216.

13. Menon TJ, Thjellesen D, Wroblewski BM. Charnley low-friction arthroplasty in diabetic patients. J Bone Joint Surg Br. 1983. 65:580–581.

14. Michelson JD, Lotke PA, Steinberg ME. Urinary-bladder management after total joint-replacement surgery. N Engl J Med. 1988. 319:321–326.

15. England SP, Stern SH, Insall JN, Windsor RE. Total knee arthroplasty in diabetes mellitus. Clin Orthop Relat Res. 1990. 260:130–134.

16. Sutherland CJ, Schurman JR. Complications associated with warfarin prophylaxis in total knee arthroplasty. Clin Orthop Relat Res. 1987. 219:158–162.

17. Drennan DB, Fahey JJ, Maylahn DJ. Important factors in achieving arthrodesis of the Charcot knee. J Bone Joint Surg Am. 1971. 53:1180–1193.

18. Einhorn TA, Boskey AL, Gundberg CM, Vigorita VJ, Devliu VJ, Beyer MM. The mineral and mechanical properties of bone in chronic experimental diabetes. J Orthop Res. 1988. 6:317–323.

19. Alvin CP. Dennis LK, Eugene B, Anthony SF, editors. Diabetes mellitus. Harrison's principles of internal medicine. 2004. 16th ed. New York: McGraw-Hill;2152–2180.

20. O'sullivan CJ, Hynes N, Mahendran B, et al. Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patient. Is HbA1C an independent risk factor and predictor of adverse outcome? Eur J Vasc Endovasc Surg. 2006. 32:188–197.

TOOLS

Similar articles